🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to fulfil regulatory requirements for registra...
Status
Completed
Location
CN001
Start Date
2012-05
Trial ID
NCT01652313
Treatments Being Tested
This study is to determine if Tyramine has any side effects on patients rec...
Status
Completed
Location
Multiple Locations
Start Date
2000-10
Trial ID
NCT00203125
Treatments Being Tested
This study evaluates the effect of rasagiline on balance in Parkinson's dis...
Status
Withdrawn
Location
Multiple Locations
Start Date
2014-09-15
Trial ID
NCT07077187
Treatments Being Tested
The objective of the study is to assess the effects of rasagiline on cognit...
Status
Unknown
Location
Marmara University
Start Date
2007-06
Trial ID
NCT00696215
Treatments Being Tested
To assess the efficacy of rasagiline 1 mg as a first add-on treatment to do...
Status
Completed
Location
Teva Investigational Site 34
Start Date
2009-12
Trial ID
NCT01049984
Treatments Being Tested
This is a study to evaluate the safety and efficacy of the IBRF ACP/MCP int...
Status
Unknown
Location
International Brain Research Foundation
Start Date
2016-03
Trial ID
NCT02696512
This study is designed to evaluate the pharmacokinetics of rasagiline in he...
Status
Completed
Location
Teva Investigational Site 10738
Start Date
2013-06
Trial ID
NCT01879748
Treatments Being Tested
The primary purpose of this extension study is to assess the long-term safe...
Status
Terminated
Location
Multiple Locations
Start Date
2010-11-18
Trial ID
NCT01215227
Treatments Being Tested
As the MAO-B inhibitor rasagiline is able to improve motor skills it might ...
Status
Completed
Location
Dresden University of Technology, Dept. of Neurology
Start Date
2011-10
Trial ID
NCT01442610
Treatments Being Tested
This is a non-randomized, dose-escalation first-in-human study to evaluate ...
Status
Completed
Location
Frontage Clinical Services, Inc.
Start Date
2022-08-22
Trial ID
NCT05523570